ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

NIH Forming Special Emphasis Panel To Review Clinical Oncology Grants

September 18, 1998

Rev/Vel/Dex Response Rate High In Phase I/II Study

January 25, 2008

‘Meta-analysis’ Of Early Breast Cancer Trials finds Adjuvant Therapy Significantly Prolongs Life

January 10, 1992

House Appropriators Approve NIH Increase; Clinton Threatens Veto Over Education Cuts

July 17, 1998

‘Major Discover’ At FCRDC Is NF1 Gene, Report Says

November 30, 1990

Einhorn Sees More Results Coming Similar to Big Successes in Testicular Cancer

May 15, 1981